Skip to main content
PMC home page
The Journal of the Royal College of General Practitioners logoLink to The Journal of the Royal College of General Practitioners
. 1984 Nov;34(268):611–614.

Latest views on pill prescribing.

C R Kay
PMCID: PMC1960069  PMID: 6502571

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burslem R. W. Cervical cytological screening for users of oral contraceptives. Lancet. 1983 Oct 22;2(8356):968–968. doi: 10.1016/s0140-6736(83)90482-8. [DOI] [PubMed] [Google Scholar]
  2. Böttiger L. E., Boman G., Eklund G., Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet. 1980 May 24;1(8178):1097–1101. doi: 10.1016/s0140-6736(80)91550-0. [DOI] [PubMed] [Google Scholar]
  3. Edgren R. A., Sturtevant F. M. Potencies of oral contraceptives. Am J Obstet Gynecol. 1976 Aug 15;125(8):1029–1038. doi: 10.1016/0002-9378(76)90804-8. [DOI] [PubMed] [Google Scholar]
  4. Inman W. H., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J. 1970 Apr 25;2(5703):203–209. doi: 10.1136/bmj.2.5703.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kay C. R. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):762–765. doi: 10.1016/s0002-9378(16)32485-1. [DOI] [PubMed] [Google Scholar]
  6. Khaw K. T., Peart W. S. Blood pressure and contraceptive use. Br Med J (Clin Res Ed) 1982 Aug 7;285(6339):403–407. doi: 10.1136/bmj.285.6339.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. McPherson K., Neil A., Vessey M. P., Doll R. Oral contraceptives and breast cancer. Lancet. 1983 Dec 17;2(8364):1414–1415. doi: 10.1016/s0140-6736(83)90936-4. [DOI] [PubMed] [Google Scholar]
  8. Meade T. W., Greenberg G., Thompson S. G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J. 1980 May 10;280(6224):1157–1161. doi: 10.1136/bmj.280.6224.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oral contraceptives and cancer. Lancet. 1983 Oct 29;2(8357):1018–1020. [PubMed] [Google Scholar]
  10. Orme M. L., Back D. J., Breckenridge A. M. Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet. 1983 Mar-Apr;8(2):95–136. doi: 10.2165/00003088-198308020-00001. [DOI] [PubMed] [Google Scholar]
  12. Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
  13. Rosenberg L., Miller D. R., Kaufman D. W., Helmrich S. P., Stolley P. D., Schottenfeld D., Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol. 1984 Feb;119(2):167–176. doi: 10.1093/oxfordjournals.aje.a113735. [DOI] [PubMed] [Google Scholar]
  14. Vessey M. P., Lawless M., McPherson K., Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet. 1983 Oct 22;2(8356):930–934. doi: 10.1016/s0140-6736(83)90451-8. [DOI] [PubMed] [Google Scholar]
  15. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners

RESOURCES